DeepIntent this week announced a suite of live sports and events advertising capabilities for healthcare and pharmaceutical companies, marking what the New York-based demand-side platform describes as an industry first: the ability to target verified, premium live streaming TV inventory at scale while measuring outcomes in terms specific to the pharmaceutical industry.

The announcement, made June 9, 2026, arrives at a moment when live sports viewership has migrated decisively toward streaming platforms - but the infrastructure to reach those viewers with precise, compliant healthcare advertising has lagged well behind. According to DeepIntent, 96 of the 100 most-watched telecasts in the United States in 2025 featured live sports. That concentration of viewership in live programming, combined with its accelerating shift toward connected TV apps, forms the market context for the product launch.

A gap in the live CTV market

Most major demand-side platforms have added live CTV features as streaming audiences expanded over the past two years. The problem, according to DeepIntent, is structural rather than superficial. Live events inventory is routinely mixed with other inventory types in the bidstream, making it difficult for any advertiser - and particularly difficult for pharmaceutical advertisers with strict compliance and measurement requirements - to verify that a campaign is actually running against live moments rather than on-demand replays or adjacent content.

For healthcare brands, that ambiguity carries real cost. Pharmaceutical advertising operates under regulatory frameworks that demand precision in targeting and transparency in measurement. Broad inventory bundles that include live signals without verification offer reach without confidence. DeepIntent's argument is that confidence, not just reach, is the missing piece.

Live CTV has attracted considerable infrastructure investment across the industry. Magnite launched its Live Scheduler tool in November 2025, building a standardized framework for media owners and advertisers to plan, activate, and measure advertising around live streaming events. Google Ad Manager introduced CTV live-biddable capabilities in November 2025, enabling publishers to monetize unpredictable live events through real-time programmatic transactions. At NewFront 2026, Google further announced a live sports biddable suite for Display and Video 360, directly addressing what programmatic buyers had identified as a structural gap when moving budgets from linear television. According to industry data cited across multiple analyses, 82 percent of programmatic buyers plan to increase live CTV investment over the next 12 months.

None of that infrastructure, however, was built with pharmaceutical compliance or healthcare-specific measurement as primary design constraints. DeepIntent is positioning its launch precisely in that space.

AEGIS 1: the data center behind the targeting

The technical foundation for the new capabilities is AEGIS 1, a multi-million dollar AI data center environment that DeepIntent built specifically to handle the complexity of delivering precise, privacy-safe advertising within live event programming. The company describes AEGIS 1 as capable of scaling deterministic targeting across millions of ad opportunities per second, including the peak demand generated by concurrent viewership during live sports and event streams.

That computational requirement is not trivial. Live sports generates audience spikes that are structurally different from on-demand streaming content. When a goal is scored, or a game enters overtime, viewership and advertiser demand can surge simultaneously and without warning. Standard programmatic infrastructure, designed for predictable inventory flows, struggles to maintain targeting precision and delivery quality under those conditions. AEGIS 1 is DeepIntent's answer to that engineering challenge.

Deterministic targeting at the scale that live events demand requires processing enormous volumes of bid requests in real time while simultaneously applying healthcare-specific identity graphs - ones that connect ad impressions to verified patient and healthcare provider identities. Doing that at millions of impressions per second, under conditions of unpredictable demand, is what differentiates an AI data center purpose-built for the task from general-purpose programmatic infrastructure.

Four capabilities in the product suite

DeepIntent's Live Events and Sports offering consists of four distinct components, each addressing a different operational challenge.

Verified live inventory from trusted publisher partners

Live signals in the bidstream are, according to DeepIntent, notoriously unreliable. Publishers and supply-side platforms often transmit live indicators that do not accurately reflect the actual content type being served. DeepIntent has addressed this by partnering directly with publishers and SSPs upfront to create Private Marketplace deals consisting entirely of confirmed live inventory across all major sports events. Advertisers can also activate their own negotiated live inventory through Programmatic Guaranteed and PMP deals within the platform. The PMP and PG structure puts inventory transparency upstream of the auction, rather than attempting to filter for live signals post-bid.

Custom live delivery algorithm

The timing constraints of live events are categorically different from those of standard programmatic campaigns. A live sports match generates advertising value during a narrow, defined window. Miss that window - through slow pacing, delivery errors, or infrastructure latency - and the premium nature of the inventory is lost entirely. DeepIntent has developed a custom pacing algorithm built specifically for these high-stakes, time-compressed windows, designed to maximize delivery during the moments that matter most rather than spreading impressions evenly across a campaign flight.

Simple activation via one-click template

A one-click toggle activates a Live Events Ad Group Template with prebuilt presets, reducing the operational complexity of setting up campaigns against live inventory. Premium PMP and PG deals span major sports leagues and networks, providing impression availability throughout a game, tournament, or season. This design choice reflects a practical observation: pharmaceutical advertising operations teams are not structured for last-minute campaign configuration. The faster the activation process, the more accessible live events become as a channel.

Live optimization against pharma KPIs

This is perhaps the most technically specific element of the suite. Live campaigns can be isolated and evaluated in real time through DeepIntent Outcomes, the company's patented measurement product. The available insights enable faster optimization - not against the generic engagement metrics common to most CTV platforms, but against pharmaceutical-specific key performance indicators. According to DeepIntent, this capability is unmatched by other platforms.

Pharma KPIs and why they matter for measurement

Script lift - a measurement of whether physicians exposed to advertising subsequently prescribed the advertised drug at higher rates than unexposed physicians - is a defining metric in pharmaceutical advertising. It is also a metric that most general-market CTV platforms are neither designed nor equipped to track.

Connecting script lift and patient reach quality to live CTV campaigns requires a data infrastructure that combines media delivery records with clinical outcome data. That combination, operating within the compliance boundaries required for pharmaceutical advertising, is what DeepIntent has built DeepIntent Outcomes to provide. Extending that measurement capability to live events inventory specifically is the gap this product launch addresses.

Kristy Quagliariello, Vice President of Programmatic Media at Klick Health, a healthcare agency, described the significance: "Live events represent one of the most under-utilized channels in healthcare and pharma media, not because of lack of interest, but because the infrastructure to execute with confidence simply hasn't existed." Quagliariello added that "what sets DeepIntent's capability apart isn't just the verified inventory or the pacing built for the nuances of live programming, it's that measurement is anchored in pharma KPIs from the start."

Quagliariello identified three specific outcomes the capability enables measuring: script lift, patient and healthcare provider reach quality, and real-world behavior change. That specificity matters. Live CTV has generated interest among pharmaceutical marketers for years, but the absence of outcome measurement anchored in clinical data has made it difficult to justify budget allocation against what remained an unverified channel.

The live sports backdrop in 2026

The commercial timing of the launch aligns with a concentrated calendar of major live sports events. According to DeepIntent, fans are preparing to watch events including the World Cup, NBA, WNBA, MLB, and NFL across all major streaming platforms. The World Cup in particular represents a scale moment for streaming live sports, with audiences across streaming platforms expected to be significant. In 2025, live sports events across soccer, football, basketball, and baseball drove the overwhelming majority of high-viewership streaming moments.

Those trends are expected to continue through 2026. The concentration of audiences in live moments - and the premium that advertisers have historically placed on adjacency to live sports - creates the economic rationale for the investment DeepIntent has made in AEGIS 1 and the supporting tooling.

Ian Colley, Chief Marketing Officer of DeepIntent, framed the company's position: "As consumers gravitate to the excitement of live sports, advertisers are looking for ways to reach them in those moments, whether it's the World Cup, basketball playoffs, baseball, or football. Our focus has always been bringing healthcare and pharma advertisers the most advanced capabilities in ad tech, with the compliance and measurement infrastructure the industry requires."

Context: DeepIntent's expanding platform

The live sports launch is the latest in a series of product extensions DeepIntent has made over the past year, all moving in the direction of a more comprehensive healthcare advertising infrastructure. In August 2025, DeepIntent launched a FAST solution for healthcare streaming ads, targeting verified patients and healthcare providers across premium streaming platforms including FAST channels. According to the company's viewership analysis at the time, 77% of healthcare providers are reachable through FAST channels.

In September 2025, DeepIntent added audio to its connected TV offering, partnering with iHeartMedia and SiriusXM and positioning itself as the first major healthcare DSP to unify CTV and audio under a single suite. The HealthFirst Audio Package was designed to reach patients and healthcare providers during what the company called high-attention, screen-free moments.

In March 2026, DeepIntent launched Helix, a HIPAA-compliant healthcare marketing cloud covering 3.7 million healthcare providers and 240 million patient lives. Helix opened DeepIntent's core data infrastructure to third-party partners, reflecting a strategic shift from DSP operator to infrastructure provider. The platform included support for the Model Context Protocol, placing it within the broader movement in ad tech toward agentic AI interoperability.

More recently, in late May 2026, DeepIntent announced three point-of-care deals in a single week, including integrations with OptimizeRx's authenticated EHR network, epocrates' in-workflow clinician inventory, and Lane4.io - an SSP purpose-built for EHR and health media advertising covering 6 EHR systems and 158,000 unique doctors. The epocrates partnership, announced May 26, 2026, made epocrates' clinical advertising inventory programmatically accessible through a DSP for the first time.

The live sports suite fits within this trajectory. DeepIntent has been systematically closing the gaps between healthcare advertising ambition and execution capability - moving from FAST channels to audio to clinical point-of-care, and now to live premium sports CTV. Each expansion has added a channel type that was previously inaccessible to pharmaceutical advertisers with confidence.

What this means for the marketing community

The broader significance for marketing professionals extends beyond any single product capability. The live CTV advertising infrastructure is still being built across the industry. IAB Europe published a comprehensive guide to programmatic CTV in April 2026, mapping the technical landscape including DSP-SSP interactions, SSAI implementation, and regulatory context. Live events have been a recurring theme in that standardization work, with the Live Event Ad Playbook under development as an industry framework.

Healthcare advertisers represent a specific and demanding segment of that ecosystem. Their requirements for deterministic targeting, compliance-safe data handling, and outcome measurement tied to clinical data are more stringent than general market advertisers. Platforms that solve those requirements for pharmaceutical companies tend to build infrastructure that raises the quality bar across the category.

The question of live sports as a pharmaceutical advertising channel is not new. What DeepIntent is offering is an answer to the execution questions that have kept pharma dollars on the sidelines: where exactly is the verified live inventory, how does delivery pace correctly within tight event windows, and how does measurement connect back to the outcomes that pharmaceutical marketing teams are accountable for.

DeepIntent's Live Sports and Events capabilities are available now.

Timeline

Summary

Who: DeepIntent, a New York-based healthcare demand-side platform, alongside healthcare agency Klick Health.

What: The launch of Live Sports and Events advertising capabilities for pharmaceutical and healthcare companies, consisting of verified live CTV inventory through Private Marketplace and Programmatic Guaranteed deals, a multi-million dollar AI data center (AEGIS 1) enabling deterministic targeting at millions of ad opportunities per second, a custom pacing algorithm built for live event delivery windows, and real-time optimization against pharma-specific KPIs through the patented DeepIntent Outcomes measurement product.

When: Announced June 9, 2026. Capabilities are available immediately for activation within the DeepIntent DSP.

Where: Available within DeepIntent's DSP platform, accessible to healthcare brands and their agencies globally. DeepIntent is headquartered in New York.

Why: Live sports generated 96 of the 100 most-watched US telecasts in 2025, and those events are increasingly consumed through streaming TV apps. Despite clear audience concentration, pharmaceutical advertisers have been unable to target live CTV confidently because live inventory signals in the bidstream are unreliable, standard DSPs mix live with non-live inventory, and no platform had previously connected live event delivery to pharma-specific outcome metrics such as script lift and healthcare provider reach quality.